CareDx HLA Typing Services support research and academic institutions working on HLA applications in vaccine and drug development, disease association as well as autoimmunity studies. This service is currently active out of CareDx’s fully functional next generation sequencing (NGS) HLA typing service lab in Stockholm, Sweden.

What are the Benefits?

CareDx HLA typing service is powered by AlloSeq Tx17 — this enables best-in-class research by using innovative hybrid-capture technology with the highest level of resolution. Benefits include:

  • No long-range PCR inefficiencies
  • A fast turnaround times
  • 50% more gene content than other NGS solutions on the market, including 11 classical HLA loci as well as HLA-E, -F, -G, -H, MICA, and MICB

Learn more about AlloSeq Tx 17 – click here

Reach out to us for more information: